Table 2 Comparison of the overall prevalence of oocyte dysmorphisms in the GnRH agonist and GnRH antagonist groups
From: GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
Oocyte characteristics | Total n: 681 | Group | Â | P | Odds ratio (95% CI) | Â |
|---|---|---|---|---|---|---|
Agonist | Antagonist | Â | ||||
n: 330 | n: 351 | Â | ||||
Oocytes: |  |  |  | 0.34 | 1.29 (0.75–2.22) |  |
Normal | 27.8% (189) | 25.8% (85) | 29.6% (104) | Â | Â | |
Dysmorphic | 72.2% (492) | 74.2% (245) | 70.4% (247) | Â | Â | Â |
Cytoplasmic dysmorphism | 32.3% (220) | 32.1% (106) | 32.5% (114) | 0.84 | 1.05 (0.61–1.80) |  |
Extracytoplasmic dysmorphism | 18.2% (124) | 19.4% (64) | 17.1% (60) | 0.48 | 0.78 (0.37–1.59) |  |
Cytoplasmic + extracytoplasmic dysmorphism | 21.7% (148) | 22.7% (75) | 20.8% (73) | 0.45 | 0.77(0.38–1.54) |  |